Navigation Links
OrthoAccel Technologies Announces Full-Market Release of AcceleDent, a New Technology to Shorten Treatment Time in Braces
Date:8/31/2010

HOUSTON, Aug. 31 /PRNewswire/ -- OrthoAccel Technologies, Inc. announced this week that following a successful limited market release of AcceleDent last October it will be initiating a full-market release throughout the United Kingdom this coming September.  Availability of AcceleDent, which is a regulated medical device and only available to dental professionals to prescribe to their patients, will be featured at the British Orthodontic Conference (BOC) next month in Brighton.

(Logo:  http://photos.prnewswire.com/prnh/20091029/DA01250LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20091029/DA01250LOGO)

AcceleDent is a simple, removable dental device that patients place in the mouth for twenty minutes daily.  It produces a gentle vibrational force which enhances the pressure applied by braces.  AcceleDent has been clinically proven to safely speed up orthodontic tooth movement.  The product is hands-free and allows the user flexibility to carry out most routine tasks during use.  

The AcceleDent System is currently being sold to select orthodontic specialists in the United Kingdom, where it was introduced last year through a limited market release program.  Approximately twenty orthodontic specialists participated in the evaluation program, which the Company used as an important learning experience.  Mike Kaufman, VP Marketing and Business Development at OrthoAccel, commented, "The controlled UK introduction has provided an invaluable opportunity to experience customer purchasing preferences and marketing approaches to incorporate AcceleDent into the orthodontic treatment plan.  The ability to intimately dialogue with these early adopter orthodontists has yielded several product refinements, which have already been implemented.  These orthodontists are very encouraged by the results they are seeing and in general have been able to move through the treatment plan at a quicker pace."

Patients have reported using the device while engaged in a variety of activities, including homework, watching television and reading.  The vibrating force has been described as "very light," and one patient remarked, "The pulsing feels like a gentle massage for my teeth and gums – and I look forward to it every evening."  

And it seems that every patient has a unique story driving the desire to complete treatment and reach the final result of a beautiful smile as quickly as possible.  "I definitely want to finish treatment before I go to university, and plan to travel for the second six months of my gap year. Clear braces mean I don't feel nearly so self conscious and AcceleDent means I can expect to finish all my treatment by the end of this year - which is really great," remarked James, a 17 year old patient under the care of Dr Sharon Orton-Gibbs at Walpole Specialists, Surbiton.

The Company has reported plans to host a gathering at the BOC in Brighton next month for the group of early-user orthodontic specialists, in order to review patient case progress and other insights.  OrthoAccel is anticipating the conclusion of another US clinical trial at the UT Health Science Center in San Antonio with a target completion date later in 2010.

About OrthoAccel Technologies, Inc.

Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.  

About the AcceleDent System

AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology.  The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies.  AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States.  More information can be found at www.acceledent.com or requested via info@orthoaccel.com


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. OrthoAccel Technologies, Inc. and AB Orthodontics Announce Partnership and Australian Product Introduction
2. OrthoAccel Technologies, Inc. Announces Definitive Distribution Agreements in Two Key Markets
3. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
4. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
5. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
6. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
7. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
8. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
9. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... MONTREAL , May 4, 2017  Fortuna Fix Inc. (" ... aiming to be the first to eliminate the need for ... autologous cells to treat neurodegenerative diseases. Fortuna ... ("SAB") with Professor Michael Fehlings , MD, PhD; Father ... Hack , MD, MPH; and Professor James Giordano , ...
(Date:5/4/2017)... and SAN DIEGO , May 4, ... (ACOG) 2017 Annual Clinical and Scientific Meeting— OBP Medical ... medical devices, today announced the launch of a new ... OfficeSPEC and ER-SPEC vaginal specula. Already ... extra-small and extra-large sizes makes OBP Medical,s line of ...
(Date:5/4/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ... clinical grade hypothermic storage and cryopreservation ... that the Company,s first quarter 2017 financial results will ... 2017, and that the Company will host a conference ... afternoon. Management will provide an overview of the Company,s ...
Breaking Medicine Technology:
(Date:5/23/2017)... ... May 23, 2017 , ... The Gallery of ... Sadati, is pleased to announce a new treatment option called Vivace Microneedling. This ... face, neck, and body through a virtually pain-free, non-surgical treatment. Vivace Microneedling combines ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... Specialists, are educating patients on peri-implantitis in Las Vegas, NV, and ... receive a custom gum disease consultation and leading care for peri-implantitis, with or ...
(Date:5/23/2017)... ... 2017 , ... Diagnotes, an Indianapolis-based digital healthcare communication company, ... secure clinical communication platform. The platform allows clinicians to easily escalate their preferred ... urgency of a situation. , “We know from our daily lives that ...
(Date:5/23/2017)... ... ... Orbita’s Nathan Treloar will discuss the role of voice-powered healthcare applications during ... Health and IoT: Technology Innovators and Disruption , the workshop is part of ... and consulting firm specializing in emerging consumer technology products and services. , Orbita, ...
(Date:5/23/2017)... ... May 23, 2017 , ... New ... the SPEED System™ Orthodontics, with or without a referral, from the multi-specialty Dr. ... Segundo, CA, who is skilled in providing patients with the custom, convenient and ...
Breaking Medicine News(10 mins):